Ola Kragsterman | Commercial Head – Lean Digital Core Program
Novartis

20+ years of commercial leadership experience in life sciences, spanning commercial disease area strategy, brand building, market execution and digital innovation. Proven country leadership across markets including the US and Germany, combined with international brand leadership experience. Currently leading commercial transformation at Novartis, with a focus on digital, automation and AI, following international brand leadership roles in hematology.

Appearances:

Festival of Biologics Day 1 @ 15:10

Panel Discussion: From Research to GMP: Making MSC Manufacturing Reproducible at Scale

Reproducibility as the differentiator: what actually drives batch‑to‑batch consistency in adherent MSC expansion (process + surface + media).
Scale-up pathways: planar scale-out (stacked/closed configurations) vs microcarriers/bioreactors—decision criteria, risks, and “go/no‑go” signals.
De-risking operations: reducing interventions (e.g., fewer media exchanges) and simplifying workflows without sacrificing phenotype/potency intent.
Translating to GMP reality: closed/assembled solutions, documentation expectations, and practical lessons learned moving from development to clinical manufacturing.

Tom Valentin, Group Leader - Automated Sample Handling, CSEM SA

Alessandro Linciano, Site MS & T Head & Technology Lead, Cell and Gene Therapies, Novartis

Moderator: Ola Kragsterman, Commercial Head – Lean Digital Core Program, Novartis

Moritz von Stosch, Partner and Founder, HINA Bioventures